Chargement en cours...
Benefits of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A Systematic Review and Meta-Analysis
Background. The adjuvant use of mitotane on adrenocortical carcinoma (ACC) has always been in controversy. We aimed to assess the prognostic benefits of adjuvant mitotane after resection of ACC in patients without distant metastasis. Methods. The PubMed, WoS, Embase, and Cochrane Library databases w...
Enregistré dans:
Auteurs principaux: | , , , , , |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
Hindawi Limited
2018-01-01
|
Collection: | BioMed Research International |
Accès en ligne: | http://dx.doi.org/10.1155/2018/9362108 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|